Home / Health / NB COVID Vaccine: Pfizer Supply Plentiful, Moderna Dominates
NB COVID Vaccine: Pfizer Supply Plentiful, Moderna Dominates
18 Dec, 2025
Summary
- New Brunswick has ample Pfizer and Moderna COVID-19 vaccine doses.
- Moderna vaccines significantly outweigh Pfizer in public supply.
- COVID-19 hospitalizations and cases are up from last year.
New Brunswick's Department of Health assures residents there is no shortage of Pfizer COVID-19 vaccines, addressing concerns that may have arisen from private market disruptions. While the province has ample supply of both Pfizer and Moderna for the current respiratory illness season, Moderna doses significantly outnumber Pfizer allocations within the publicly funded program. This disparity is due to national procurement contracts where Moderna was awarded a larger share.
As holiday gatherings approach and COVID-19 activity increases, with hospitalizations and cases higher than the previous year, public health officials emphasize the importance of timely vaccination. Currently, New Brunswick's COVID-19 activity level is considered moderate, with several outbreaks reported in long-term care homes and hospitals. The province urges individuals not to wait for a preferred vaccine, as all authorized COVID-19 vaccines are deemed safe and effective.
Vaccination rates for COVID-19 in New Brunswick are slightly down compared to the same period last year, though reporting lags may affect exact figures. With nearly 104,500 doses administered as of December 6th, officials encourage eligible residents to get vaccinated promptly. COVID-19 vaccines are available through various channels, including pharmacies and primary care providers, and can be administered alongside routine immunizations.
